Browse the evidence

In obese patients with preexisting hip or knee osteoarthritis, GLP-1 receptor agonist use is associated with a significantly reduced odds of conversion to total joint arthroplasty (THA and TKA) within one year, independent of weight loss.

If you are obese and have existing hip or knee osteoarthritis, using a GLP-1 receptor agonist (like semaglutide or liraglutide) is associated with a lower risk of needing joint replacement surgery within a year, even if your weight doesn't change significantly. This suggests the drug may have direct protective effects on your joints, not just benefits from weight loss. Discuss this potential benefit with your doctor, especially if you are considering these medications for weight management or diabetes.

Bariatric surgery induces substantial and durable weight loss in adults with severe obesity, with 89.3% of patients achieving ≥20% weight loss in the short term (0-9 years) and 81.2% maintaining this loss in the long term (10-24 years).

For individuals with severe obesity (BMI ≥40 or ≥35 with health issues), bariatric surgery is the most effective method for achieving and maintaining significant weight loss. While lifestyle changes are crucial, they rarely result in the >20% weight loss seen with surgery. Surgery provides durable benefits for over a decade, making it a viable long-term solution for severe obesity.

GLP-1 receptor agonists (GLP-1RAs) promote significant weight loss and BMI reduction in people with HIV (PWH), with tirzepatide and longer treatment duration (>6 months) being the strongest predictors of achieving >5% weight loss.

If you have HIV and are struggling with weight gain, GLP-1 receptor agonists (like semaglutide or tirzepatide) are a proven, effective treatment option. The study shows that sticking with the medication for more than 6 months and reaching the maximum dose significantly increases your chances of losing more than 5% of your body weight. Tirzepatide, in particular, showed the strongest association with significant weight loss in this population.

Incorporating biological factors (hunger, satiety, metabolic adaptation) into social cognitive theory improves long-term weight loss maintenance compared to traditional behavioral interventions that ignore these biological drivers.

If you are struggling to maintain weight loss despite eating right and exercising, recognize that your body is likely fighting back with increased hunger and a slower metabolism. This is a biological response, not a failure of willpower. To succeed, you must manage these biological signals directly by prioritizing high-satiety foods (high protein, fiber, low energy density) and strategic meal timing, rather than relying solely on mental discipline or distraction techniques.

Discontinuation of GLP-1 analogues for obesity is primarily driven by side effects (36%), logistical challenges (24%), and cost (23%), leading to significantly lower long-term weight loss compared to persistent users.

If you are taking a GLP-1 for weight loss, sticking with it is the most important factor for success. Most people stop due to side effects, cost, or logistics, not because the drug doesn't work. To stay on it, work with your doctor to titrate the dose slowly to minimize stomach issues, seek financial assistance if the cost is prohibitive, and use telemedicine to reduce logistical burdens. Persisters lose significantly more weight (nearly 18%) than those who quit early (12.6%).

Optimizing the distribution of protein intake across meals, particularly by shifting protein from dinner to post-training snacks, can improve the efficiency of muscle protein synthesis (MPS) without increasing total daily protein needs.

You don't necessarily need to eat more protein, but you should spread it out. If you eat a huge dinner, try moving some of that protein to a snack immediately after your training session. This helps your body use the protein more effectively for muscle repair.

Supplementing meals with 3-4 grams of leucine can improve or normalize muscle protein synthesis in aging muscle, acting as a trigger for the mTOR pathway.

If you are older, adding 3-4 grams of leucine to your meals (or eating leucine-rich foods like beef or whey) can help trigger muscle growth. However, if you already eat enough protein, you might not need extra leucine supplements.

High adherence to a low-carbohydrate diet score is associated with significantly lower diastolic blood pressure, lower triglyceride concentrations, and higher HDL cholesterol in obese adults.

For obese adults, adopting a dietary pattern that lowers carbohydrate intake and increases fat intake (a high LCD score) is associated with better blood pressure and lipid profiles, specifically lower triglycerides and higher HDL. However, simply shifting macros may not reduce body weight if carbohydrate intake remains above 50% of total energy.

High adherence to a low-carbohydrate diet score is associated with a reduced prevalence of metabolic syndrome in obese adults.

Adhering to a low-carbohydrate dietary pattern is linked to a lower likelihood of having metabolic syndrome in obese individuals, likely due to improvements in blood pressure and lipids.

Eloralintide (LY3841136), a selective amylin receptor agonist, promotes significant body weight loss primarily through fat mass reduction with favorable gastrointestinal tolerability compared to non-selective amylin agonists.

Eloralintide is a once-weekly injection that targets specific receptors to reduce appetite and food intake. In early trials, it led to modest but significant weight loss (up to 4.4% in 4 weeks) primarily by burning fat, with fewer stomach side effects than some competitors. It is currently in early clinical stages and not yet widely available.

EULAR guidelines recommend early and aggressive screening and management of traditional cardiovascular disease (CVD) risk factors and metabolic syndrome components for all patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).

If you have RA or PsA, ask your doctor about a comprehensive cardiovascular risk assessment, not just joint care. This includes checking for metabolic syndrome components (blood pressure, lipids, blood sugar, waist size). Follow EULAR guidelines which suggest aggressive management of these risks, potentially using medications like statins or newer diabetes drugs (SGLT2/GLP1) if appropriate, alongside lifestyle changes like quitting smoking and eating healthily.

Bodybuilding peak-week strategies involving carbohydrate supercompensation and acute water manipulation significantly increase the intracellular-to-extracellular water ratio (ICW/ECW) and phase angle, indicating fluid shifts from subcutaneous to intracellular compartments.

If you are a competitive bodybuilder, your peak week strategy of high carbohydrate intake combined with initial high water intake followed by a reduction can effectively shift water from under the skin into the muscles. This increases muscle fullness and definition (higher phase angle) even if your total body weight or total water volume decreases slightly. Monitor your bioelectrical impedance if possible to track this shift.

High carbohydrate intake (>60% of energy) is associated with higher all-cause mortality, whereas moderate intake (50-55% of energy) is associated with the lowest risk, forming a U-shaped relationship.

Aim for carbohydrates to make up about 50-55% of your daily energy intake. This moderate level is associated with the lowest risk of death in large global studies. Avoid diets that are either very high in carbs (>60%) or very low in carbs, as both extremes are linked to higher mortality. Focus on a balanced diet including fruits, vegetables, whole grains, and unprocessed meats.

Patients perceive lifestyle factors (diet, exercise) and biological factors (genetics, metabolism) as causes of obesity, but often lack understanding of the biological mechanisms, leading to a focus on willpower and emotional eating as primary determinants of weight loss maintenance.

Patients often believe that willpower and exercise are the main keys to keeping weight off, ignoring biological factors. This can lead to feelings of failure when willpower runs out. It is important to educate patients that biological factors also play a role, and that using medical interventions alongside lifestyle changes is valid and effective.

Patients perceive emotional eating, driven by stress, depression, and childhood adversity, as a significant cause of obesity and a barrier to weight loss maintenance.

For patients who eat in response to stress or depression, addressing the emotional root cause is crucial. Simply focusing on diet and exercise may not be enough. Psychological support and coping strategies can help manage emotional eating.

Even protein distribution is associated with lower-body muscular endurance, but not functional ability (gait speed or chair stand tests) in healthy women.

If your goal is muscular endurance (e.g., ability to perform repeated movements), spreading protein to meet relative targets (0.24 g/kg for <60yo, 0.4 g/kg for ≥60yo) per meal may help. However, do not expect this to directly improve your walking speed or daily functional tasks like chair stands if you are already healthy and active.

Frequent eating out of home (1-5 times/week or >6 times/week) is negatively correlated with daily vegetable and fruit intake and positively correlated with meat and aquatic product intake.

If you eat out frequently, you are likely consuming fewer fruits and vegetables and more meat/aquatic products than if you cooked at home. To counteract this, consciously prioritize vegetable-heavy dishes when dining out, or ensure your home-cooked meals are rich in produce to balance your weekly intake.

Frequent eating out of home is negatively correlated with sleep duration and physical activity time.

Frequent eating out is linked to shorter sleep and less physical activity. If you eat out often, be aware that this may be part of a broader pattern of reduced self-care. Try to schedule sleep and exercise as non-negotiable appointments, even if it means preparing simpler meals at home.

Nudge techniques (environmental modifications influencing behavior) result in modest but significant weight loss, particularly in men with severe obesity.

Modify your environment to make healthy choices easier (e.g., keep healthy food visible, remove unhealthy food from sight). This is particularly effective for men with severe obesity.

Daily administration of 100 mg mirabegron (a selective β3-AR agonist) increases energy expenditure and skin temperature in humans without cardiovascular side effects, offering a pharmacological alternative to cold exposure for activating brown adipose tissue.

If you are looking to boost metabolic rate through medication, 100 mg of mirabegron daily has been shown in studies to increase energy expenditure and skin temperature without causing heart issues. This is a repurposed drug originally for bladder issues, but it targets fat-burning pathways. Note that higher doses (150-200mg) may cause heart rate and blood pressure increases, so 100mg is the identified safe effective dose in the cited research.

GLP-1 receptor agonists are cost-effective for expanding access to obesity treatment, particularly for patients ineligible for or hesitant about surgery, and can serve as a bridge to surgery or adjunct for post-surgical regain.

If you cannot have surgery due to health risks, insurance, or wait times, GLP-1 medications are a viable, evidence-based option. They can help you lose enough weight to become a surgical candidate or manage weight after surgery. However, be prepared for lifelong use to maintain results.

GLP-1 receptor agonists (GLP-1RAs) are perceived by current and past users as safe and effective for weight loss, with users strongly disagreeing that risks outweigh benefits, whereas non-users exhibit significant skepticism regarding safety and efficacy.

If you are considering GLP-1RAs, be aware that skepticism about safety and cost are common barriers, especially if you haven't used them. However, data from current and past users shows they strongly disagree that risks outweigh benefits and highly recommend the medication. Consult a healthcare provider to address specific safety concerns and cost barriers, as user experience often contradicts public skepticism.

Amateur male bodybuilders consuming high-protein diets (average 1.8 g/kg, up to 3.7 g/kg) combined with protein supplements exhibit significantly higher body fat percentages and thigh skinfold thickness compared to those with lower protein intake.

If you are an amateur bodybuilder, be careful with protein supplements. This study found that higher protein intake, especially from supplements, was linked to higher body fat. You likely don't need more than 1.6-1.8 g/kg of protein from food alone. Focus on whole food sources and avoid stacking multiple protein supplements, as this may lead to excess calories and fat gain rather than muscle.

Neuromuscular electrical stimulation-based resistance training (NMES-RT) is the most robust and consistent intervention for increasing skeletal muscle mass in the paralyzed limbs of persons with chronic, motor complete spinal cord injury.

For individuals with chronic, complete spinal cord injury aiming to increase muscle mass, NMES-based resistance training (specifically the Dudley Protocol) is the most effective current strategy. This involves performing 3-4 sets of 10 electrically stimulated knee extensions twice weekly with progressive resistance. While other methods like FES cycling or pharmacological treatments exist, NMES-RT yields the largest and most consistent muscle growth, particularly in the quadriceps.